WVE — Wave Life Sciences Share News
0.000.00%
Last trade - 00:00- $660.71m
- $170.11m
- $42.73m
Wave Life climbs on positive data for Huntington's therapy
Brief: Wave Life Sciences Announces Positive Results From Phase 1B/2A Select-Hd Trial
Wave Life Sciences Ltd Expected To Post A Loss Of 21 Cents A Share: Earnings Preview
Brief: Wave Life Sciences Remains On Track To Deliver Proof-Of-Mechanism Data Measured By Restoration Of M-AAt Protein In Serum
Wave Life Sciences Ltd Expected To Post A Loss Of 21 Cents A Share: Earnings Preview
Brief: Wave Life Sciences On Track To Initiate Clinical Trial Of Its INHBE Program In Q1 2025
U.S. STOCKS ON THE MOVE-Silver miners, Albemarle, Pfizer
U.S. STOCKS ON THE MOVE-Couchbase, Foot Locker, Nordstrom
Wave Life Sciences rises on Q4 revenue beat, smaller-than-expected loss
Wave Life Sciences Ltd Reports Results For The Quarter Ended In December: Earnings Summary
Brief: Wave Life Sciences Says Well-Capitalized Following $142 Mln Of Cash Inflows In Q4 2023
U.S. STOCKS ON THE MOVE-Rockwell Automation, Crinetics Pharmaceuticals, TransUnion
U.S. STOCKS ON THE MOVE-Arvinas, FMC Corp, Wave Life Science
Wave Life Sciences rises as Leerink upgrades to 'outperform', lifts PT
U.S. STOCKS ON THE MOVE-Veeva systems, Alphabet, Moderna
U.S. STOCKS ON THE MOVE-Dollar General, J.B. Hunt, Bristol-Myers
Wave Life Sciences slides after pricing public offering
Brief: Wave Life Sciences Prices $100 Million Public Offering Of Ordinary Shares
Brief: Wave Life Sciences Announces Proposed Public Offering Of Ordinary Shares And Pre-Funded Warrants